- RNAC Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-3 Filing
Cartesian Therapeutics (RNAC) S-3Shelf registration
Filed: 25 Oct 23, 5:29pm
Exhibit 107
Calculation of Filing Fee Tables
Form S-3
(Form Type)
Selecta Biosciences, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security Type | Security Class Title | Fee Calculation Rule | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum Price | Fee Rate | Amount of Registration Fee | |||||||||
Fees to be Paid | Equity | Common Stock, par value $0.0001 per share | Rule 457(o) | (1) | $(1) | $— | — | $— | ||||||||
Equity | Preferred Stock, par value $0.0001 per share | Rule 457(o) | (1) | $(1) | — | — | — | |||||||||
Debt | Debt Securities (3) | Rule 457(o) | (1) | $(1) | — | — | — | |||||||||
Other | Warrants | Rule 457(o) | (1) | $(1) | — | — | — | |||||||||
Other | Units | Rule 457(o) | (1) | $(1) | — | — | — | |||||||||
Unallocated (Universal) | — | Rule 457(o) | $200,000,000 | — | $200,000,000 (2) | 0.00014760 | $29,520 | |||||||||
Fees Previously Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||||||
Total Offering Amounts | $200,000,000 (2) | $29,520 | ||||||||||||||
Total Fees Previously Paid | $— | |||||||||||||||
Total Fee Offsets | $— | |||||||||||||||
Net Fee Due | $29,520 |
(1) An indeterminate number or aggregate principal amount, as applicable, of securities of each identified class is being registered as may from time to time be offered on a primary basis at indeterminate prices, including an indeterminate number or amount of securities that may be issued upon the exercise, settlement, exchange or conversion of securities offered hereunder, which together shall have an aggregate initial offering price not to exceed $200,000,000. Separate consideration may or may not be received for securities that are issuable upon conversion of, or in exchange for, or upon exercise of, convertible or exchangeable securities. Pursuant to Rule 416 under the Securities Act of 1933, as amended, or the Securities Act, this registration statement shall also cover any additional securities of the registrant that become issuable by reason of any splits, dividends or similar transactions or anti-dilution adjustments.
(2) Estimated solely for the purpose of calculating the registration fee. Subject to Rule 462(b) under the Securities Act, the aggregate initial offering price of all securities issued by the registrant pursuant to this registration statement will not exceed $200,000,000.
(3) If any debt securities are issued at an original issue discount, the offering price of such debt securities shall be in such greater principal amount at maturity as shall result in an aggregate offering price not to exceed $200,000,000, less the aggregate dollar amount of all securities previously issued hereunder.